Balchem Corp (BCPC) has declared a quarterly dividend of $0.96 per share, payable to shareholders of record. This marks a 10.3% increase from the previous dividend of $0.87 per share, underscoring management's confidence in the company's financial position.
The ex-dividend date is set for December 22, 2025, meaning investors must own shares before this date to qualify for the dividend. The payment will be made on January 19, 2026, to eligible shareholders. With a current dividend yield of 2.42%, the company offers regular income to investors, reflecting its commitment to returning capital.
Balchem operates in the chemicals industry, providing specialty performance ingredients and products. The company is headquartered in Montvale, New Jersey, and employs 1,364 full-time workers. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment supplies human-grade choline nutrients and mineral amino acid chelated products, while the ANH segment focuses on nutritional products derived from microencapsulation and chelation technologies.
The announcement highlights Balchem's robust cash flow generation and capital allocation strategy. Investors often view regular dividend payments as attractive, although dividends are subject to change based on business performance and management decisions. As of November 25, 2025, Balchem boasts a market cap of $5.0 billion, a P/E ratio of 33.74, and an EPS of 4.56. Upcoming earnings reports are anticipated on April 22, 2026, with an estimated EPS of $1.35 and revenue of $272.1 million, followed by another report on July 29, 2026, projecting an EPS of $1.40 and revenue of $274.4 million.